NAME OF DOSAGE/ MECHANISM OF INDICATION CONTRAINDICATION SPECIAL SIDE EFFECTS NURSING RESPONSIBILITIES

DRUG ROUTE/ ACTION PRECAUTION &

FREQUENCY ADVERSE
EFFECTS
GENERIC DOSAGE: Rebamipide  Treatment gastric  Known  Use with Common Side  Administer orally
NAME: enhances the ulcers and hypersensitivity to caution in Effects:
100mg
after meals for best
production of duodenal ulcers Rebamipide or patients with
Rebamipide any component of hepatic or  Constipation effect
gastric mucus,
ROUTE:
increases the formulation renal  Diarrhea  Monitor patient for
prostaglandin E2 impairment  Nausea any signs of
PO  Abdominal
BRAND NAME: levels in the  Adjunct therapy discomfort gastrointestinal
FREQUENCY: gastric mucosa, for gastritis discomfort or allergic
Mucosta and scavenges  Use in pregnant or reactions
TID free radicals. It lactating women  Safety and  Educate patient to
promotes healing should be avoided efficacy in
unless clearly children have
Adverse Effects: report any unusual
of gastric and Prevention of
duodenal ulcers

needed not been skin reactions, rashes,
gastric mucosal  Rash
by stimulating lesions induced by
established  Pruritus
or persistent
endogenous NSAIDs  Hypersensitivity abdominal pain
CLASSIFICATION AVAILABILITY protective factors reactions (rare)  Evaluate effectiveness
THERAPEUTIC and improving  Anaphylactoid by assessing reduction
TABLET: reactions
CLASS: microcirculation  Monitor for in ulcer symptoms
and mucosal signs of  Shock
100mg  Encourage
Anti-ulcer agent hypersensitivi  thrombocytope
defense.
ty nia compliance with full
 jaundice course of therapy
PHARMACOLOGIC
CLASS:  hepatic  Instruct patient to
dysfunction
Gastrointestinal
avoid NSAIDs unless
mucosal directed by a
protective agent healthcare provider